Lates News

Sonoma Pharmaceuticals (SNOA.US): The Q4 2025 financial report shows a revenue of $3.754 million, up from $3.439 million, with an expected value of $4.44 million; earnings per share were -$0.48, compared to -$1.39, with an expected value of -$0.60.